{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T10:37:13Z","timestamp":1726483033403},"reference-count":93,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2009,10,17]],"date-time":"2009-10-17T00:00:00Z","timestamp":1255737600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nervenarzt"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1007\/s00115-009-2865-3","type":"journal-article","created":{"date-parts":[[2009,10,16]],"date-time":"2009-10-16T23:36:25Z","timestamp":1255736185000},"page":"181-193","source":"Crossref","is-referenced-by-count":7,"title":["Impfen und Multiple Sklerose"],"prefix":"10.1007","volume":"81","author":[{"given":"M.","family":"L\u00f6bermann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Winkelmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.C.","family":"Reisinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.K.","family":"Zettl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,10,17]]},"reference":[{"key":"2865_CR1","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1600-0404.2008.01131.x","volume":"119","author":"Ahlgren","year":"2009","unstructured":"Ahlgren C, Od\u00e9n A, Tor\u00e9n K, Andersen O (2009) Multiple sclerosis incidence in the era of measles-mumps-rubella mass vaccinations. Acta Neurol Scand 119:313\u2013320","journal-title":"Acta Neurol Scand"},{"key":"2865_CR2","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1056\/NEJM200102013440502","volume":"344","author":"Ascherio","year":"2001","unstructured":"Ascherio A, Zhang SM, Hern\u00e1n MA et al (2001) Hepatitis B vaccination and the risk of multiple sclerosis. N Engl J Med 344:327\u2013332","journal-title":"N Engl J Med"},{"key":"2865_CR3","doi-asserted-by":"crossref","unstructured":"Baumhackl U, Franta C, Retzl J et al (2003) A controlled trial of tick-borne encephalitis vaccination in patients with multiple sclerosis. Vaccine 21 [Suppl 1]:56\u201361","DOI":"10.1016\/S0264-410X(02)00815-0"},{"key":"2865_CR4","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/S1590-8658(00)80266-2","volume":"32","author":"Bogdanos","year":"2000","unstructured":"Bogdanos DP, Mieli-Vergani G, Vergani D (2000) Virus, liver and autoimmunity. Dig Liver Dis 32:440\u2013446","journal-title":"Dig Liver Dis"},{"key":"2865_CR5","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1093\/brain\/awf098","volume":"125","author":"Buljevac","year":"2002","unstructured":"Buljevac D, Flach HZ, Hop WC et al (2002) Prospective study on the relationship between infections and multiple sclerosis exacerbations. Brain 125:952\u2013960","journal-title":"Brain"},{"key":"2865_CR6","doi-asserted-by":"crossref","first-page":"471","DOI":"10.7326\/0003-4819-92-4-471","volume":"92","author":"Briggs","year":"1980","unstructured":"Briggs WA, Rozek RJ, Migdal SD (1980) Influenza vaccination in kidney transplant recipients: cellular and humoral immune responses. Ann Intern Med 92:471\u2013477","journal-title":"Ann Intern Med"},{"key":"2865_CR7","unstructured":"British Society of Rheumatology (2002) Vaccinations in the immunocompromised person: Guidelines for the patient taking immunosuppressants, steroid and the new biological therapies. Online: http:\/\/www.rheumatology.org.uk\/guidelines\/guidelines_other\/vaccinations [18.06.09]"},{"key":"2865_CR8","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/0264-410X(92)90158-G","volume":"10","author":"Cao","year":"1992","unstructured":"Cao M, Sasaki O, Yamada A et al (1992) Enhancement of the protective effect of inactivated influenza virus vaccine by cytokines. Vaccine 10:238\u2013242","journal-title":"Vaccine"},{"key":"2865_CR9","first-page":"989","volume":"51","author":"Center","year":"2002","unstructured":"Center for Disease Control and Prevention (CDC) (2002) Adverse events associated with 17D-derived yellow fever vaccination \u2013 United States, 2001\u20132002. MMWR Morb Mortal Wkly Rep 51(44):989\u2013993","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2865_CR10","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1056\/NEJM200102013440501","volume":"344","author":"Confavreux","year":"2001","unstructured":"Confavreux C, Suissa S, Saddier P et al (2001) Vaccinations and the risk of relapse in multiple sclerosis. N Engl J Med 344:319\u2013326","journal-title":"N Engl J Med"},{"key":"2865_CR11","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1212\/01.wnl.0000233834.09743.3b","volume":"67","author":"Correale","year":"2006","unstructured":"Correale J, Fiol M, Gilmore W (2006) The risk of relapses in multiple sclerosis during systemic infections. Neurology 67:652\u2013659","journal-title":"Neurology"},{"key":"2865_CR12","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1093\/rheumatology\/41.8.937","volume":"41","author":"Davies","year":"2002","unstructured":"Davies K, Woo P (2002) Immunization in rheumatic diseases of childhood: an audit of the clinical practice of british paediatric rheumatology group members and a review of the evidence. Rheumatology 41:937\u2013941","journal-title":"Rheumatology"},{"key":"2865_CR13","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/BF02962261","volume":"26","author":"De","year":"1998","unstructured":"De Keyser J (1998) Safety of tetanus vaccination in relapsing-remitting multiple sclerosis. Infection 26:319","journal-title":"Infection"},{"key":"2865_CR14","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0022-510X(98)00139-7","volume":"159","author":"De","year":"1998","unstructured":"De Keyser J, Zwanikken C, Boon M (1998) Effects of influenza vaccination and influenza illness on exacerbations in multiple sclerosis. J Neurol Sci 159:51\u201353","journal-title":"J Neurol Sci"},{"key":"2865_CR15","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1055\/s-2008-1043177","volume":"121","author":"Dengler","year":"1996","unstructured":"Dengler TJ, Strnad N, Zimmermann R et al (1996) Pneumokokkenimpfung nach Herz- und Lebertransplantation \u2013 Immunantworten bei immunsupprimierten Patienten und gesunden Kontrollpersonen. Dtsch Med Wochenschr 121:1519\u20131525","journal-title":"Dtsch Med Wochenschr"},{"key":"2865_CR16","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1586\/14760584.1.4.461","volume":"1","author":"DeStefano","year":"2002","unstructured":"DeStefano F, Verstraeten T, Chen RT (2002) Hepatitis B vaccine and risk of multiple sclerosis. Expert Rev Vaccines 1:461\u2013466","journal-title":"Expert Rev Vaccines"},{"key":"2865_CR17","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1001\/archneur.60.4.504","volume":"60","author":"DeStefano","year":"2003","unstructured":"DeStefano F, Verstraeten T, Jackson LA et al (2003) Vaccinations and risk of central nervous system demyelinating diseases in adults. Arch Neurol 60:504\u2013509","journal-title":"Arch Neurol"},{"key":"2865_CR18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3201\/eid1501.080311","volume":"15","author":"Erlanger","year":"2009","unstructured":"Erlanger TE, Weiss S, Keiser J et al (2009) Past, present, and future of Japanese encephalitis. Emerg Infect Dis 15(1):1\u20137","journal-title":"Emerg Infect Dis"},{"key":"2865_CR19","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1055\/s-2008-1055507","volume":"120","author":"Flachenecker","year":"1995","unstructured":"Flachenecker P, Toyka KV, Hartung HP (1995) Aktive Schutzimpfungen bei multipler Sklerose. Dtsch Med Wochenschr 120(44):1513\u20131516","journal-title":"Dtsch Med Wochenschr"},{"key":"2865_CR20","first-page":"CD001261","volume":"Rev","author":"Fraser","year":"2007","unstructured":"Fraser A, Goldberg E, Acosta CJ et al (2007) Vaccines for preventing typhoid fever. Cochrane Database Syst Rev (3):CD001261","journal-title":"Cochrane Database Syst"},{"key":"2865_CR21","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1126\/science.2414848","volume":"230","author":"Fujinami","year":"1985","unstructured":"Fujinami RS, Oldstone MB (1985) Amino acid homology between the encephalitogenic site of myelin basic protein and virus: mechanism for autoimmunity. Science 230:1043\u20131045","journal-title":"Science"},{"key":"2865_CR22","doi-asserted-by":"crossref","unstructured":"Gelinck L, Teng Y, Rimmelzwaan G et al (2007) Poor serological response upon influenza vaccination in patients with rheumatoid arthritis treated with rituximab. Ann Rheum Dis 66 [Suppl II]:160 (Abstr THU0116)","DOI":"10.1136\/ard.2007.071878"},{"key":"2865_CR23","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1086\/587063","volume":"46","author":"Gl\u00fcck","year":"2008","unstructured":"Gl\u00fcck T, M\u00fcller-Ladner U (2008) Vaccination in patients with chronic rheumatic or autoimmune diseases. Clin Infect Dis 46(9):1459\u20131465","journal-title":"Clin Infect Dis"},{"key":"2865_CR24","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1155\/2007\/289842","volume":"18","author":"Gold","year":"2007","unstructured":"Gold R, Barreto L, Ferro S et al (2007) Safety and immunogenicity of a fully liquid vaccine containing five-component pertussis-diphtheria-tetanus-inactivated poliomyelitis-Haemophilus influenzae type b conjugate vaccines administered at two, four, six and 18 months of age. Can J Infect Dis Med Microbiol 18:241\u2013248","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"2865_CR25","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s100720170014","volume":"22","author":"Gout","year":"2001","unstructured":"Gout O (2001) Vaccinations and multiple sclerosis. Neurol Sci 22:151\u2013154","journal-title":"Neurol Sci"},{"key":"2865_CR26","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1055\/s-2005-918595","volume":"130","author":"Hemmer","year":"2005","unstructured":"Hemmer CJ, Littmann M, Loebermann M et al (2005) Ein Fall von FSME in Mecklenburg-Vorpommern. Dtsch Med Wochenschr 130:2507\u20132510","journal-title":"Dtsch Med Wochenschr"},{"key":"2865_CR27","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1212\/01.wnl.0000225079.51201.f9","volume":"67","author":"Hern\u00e1n","year":"2006","unstructured":"Hern\u00e1n MA, Alonso A, Hern\u00e1ndez-D\u00edaz S (2006) Tetanus vaccination and risk of multiple sclerosis: a systematic review. Neurology 67(2):212\u2013225","journal-title":"Neurology"},{"key":"2865_CR28","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2165\/00002018-200124040-00002","volume":"24","author":"Jefferson","year":"2001","unstructured":"Jefferson T, Heijbel H (2001) Demyelinating disease and hepatitis B vaccination: is there a link? Drug Saf 24:249\u2013254","journal-title":"Drug Saf"},{"key":"2865_CR29","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1128\/JVI.01718-06","volume":"81","author":"Koerner","year":"2007","unstructured":"Koerner I, Kochs G, Kalinke U et al (2007) Protective role of beta interferon in host defense against influenza A virus. J Virol 81:2025\u20132030","journal-title":"J Virol"},{"key":"2865_CR30","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1056\/NEJM199902253400810","volume":"340","author":"Koff","year":"1999","unstructured":"Koff RS (1999) The case for routine childhood vaccination against hepatitis A. N Engl J Med 340:644\u2013645","journal-title":"N Engl J Med"},{"key":"2865_CR31","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1038\/jid.2008.98","volume":"128","author":"Krueger","year":"2008","unstructured":"Krueger JG, Ochs HD, Patel P et al (2008) Effect of therapeutic integrin (CD11a) blockade with Efalizumab on immune responses to model antigens in humans: results of a randomized, single blind study. J Invest Dermatol 128:2615\u20132624","journal-title":"J Invest Dermatol"},{"key":"2865_CR32","first-page":"1326","volume":"63","author":"Kuwert","year":"1968","unstructured":"Kuwert E, Klosterk\u00f6tter W, Linzenmeier G (1968) Neurological complications following rabies vaccination. Med Klin 63:1326\u20131328","journal-title":"Med Klin"},{"key":"2865_CR33","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1007\/s00228-005-0053-3","volume":"61","author":"Laribi\u00e8re","year":"2005","unstructured":"Laribi\u00e8re A, Miremont-Salam\u00e9 G, Reyre H et al (2005) Surveillance of adverse effects during a vaccination campaign against meningitis C. Eur J Clin Pharmacol 61:907\u2013911","journal-title":"Eur J Clin Pharmacol"},{"key":"2865_CR34","doi-asserted-by":"crossref","first-page":"e1665","DOI":"10.1371\/journal.pone.0001665","volume":"3","author":"Leroux-Roels","year":"2008","unstructured":"Leroux-Roels I, Bernhard R, G\u00e9rard P et al (2008) Broad Clade 2 cross-reactive immunity induced by an adjuvanted clade 1 rH5N1 pandemic influenza vaccine. PLoS One 3:e1665","journal-title":"PLoS One"},{"key":"2865_CR35","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/S0140-6736(07)61297-5","volume":"370","author":"Leroux-Roels","year":"2007","unstructured":"Leroux-Roels I, Borkowski A, Vanwolleghem T et al (2007) Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial. Lancet 370:580\u2013589","journal-title":"Lancet"},{"key":"2865_CR36","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/S0149-2918(04)90180-4","volume":"26","author":"Loebermann","year":"2004","unstructured":"Loebermann M, Kollaritsch H, Ziegler T et al (2004) A randomized, open-lable study of the immunogenicity and reactogenicity of three lots of a combined typhoid fever\/hepatitis A vaccine in healthy adults. Clin Ther 26:1084\u20131091","journal-title":"Clin Ther"},{"key":"2865_CR37","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s12016-007-8013-6","volume":"34","author":"Maya","year":"2008","unstructured":"Maya R, Gershwin ME, Shoenfeld Y (2008) Hepatitis B Virus (HBV) and Autoimmune Disease. Clin Rev Allergy Immunol 34:85\u2013102","journal-title":"Clin Rev Allergy Immunol"},{"key":"2865_CR38","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0022-510X(96)00019-6","volume":"139","author":"Matsui","year":"1996","unstructured":"Matsui M, Kakigi R, Watanabe S, Kuroda Y (1996) Recurrent demyelinating transverse myelitis in a high titer HBs-antigen carrier. J Neurol Sci 139:235\u2013237","journal-title":"J Neurol Sci"},{"key":"2865_CR39","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1542\/peds.110.5.957","volume":"110","author":"M\u00e4kel\u00e4","year":"2002","unstructured":"M\u00e4kel\u00e4 A, Nuorti JP, Peltola H (2002) Neurologic disorders after measles-mumps-rubella vaccination. Pediatrics 110:957\u2013963","journal-title":"Pediatrics"},{"key":"2865_CR40","doi-asserted-by":"crossref","unstructured":"Merelli E, Casoni F (2000) Prognostic factors in multiple sclerosis: role of intercurrent infections and vaccinations against influenza and hepatitis B. Neurol Sci 21(4) [Suppl 2]:853\u2013856","DOI":"10.1007\/s100720070025"},{"key":"2865_CR41","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1159\/000117358","volume":"30","author":"Michielsens","year":"1990","unstructured":"Michielsens B, Wilms G, Marchal G, Carton H (1990) Serial magnetic resonance imaging studies with paramagnetic contrast medium: assessment of disease activity in patients with multiple sclerosis before and after influenza vaccination. Eur Neurol 30:258\u2013259","journal-title":"Eur Neurol"},{"key":"2865_CR42","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1093\/brain\/awl368","volume":"130","author":"Mikaeloff","year":"2007","unstructured":"Mikaeloff Y, Caridade G, Assi S et al (2007) Hepatitis B vaccine and risk of relapse after a first childhood episode of CNS inflammatory demyelination. Brain 130:1105\u20131110","journal-title":"Brain"},{"key":"2865_CR43","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1001\/archpedi.161.12.1176","volume":"161","author":"Mikaeloff","year":"2007","unstructured":"Mikaeloff Y, Caridade G, Rossier M et al (2007) Hepatitis B vaccination and the risk of childhood-onset multiple sclerosis. Arch Pediatr Adolesc Med 161:1176\u20131182","journal-title":"Arch Pediatr Adolesc Med"},{"key":"2865_CR44","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1212\/WNL.48.2.312","volume":"48","author":"Miller","year":"1997","unstructured":"Miller AE, Morgante LA, Buchwald LY et al (1997) A multicenter, randomized, double-blind, placebo-controlled trial of influenza immunization in multiple sclerosis. Neurology 48:312\u2013314","journal-title":"Neurology"},{"key":"2865_CR45","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1136\/bmj.2.5546.210","volume":"2","author":"Miller","year":"1967","unstructured":"Miller H, Cendrowski W, Shapira K (1967) Multiple sclerosis and vaccination. Br Med J 2:210\u2013213","journal-title":"Br Med J"},{"key":"2865_CR46","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1177\/135245859700300405","volume":"3","author":"Mokhtarian","year":"1997","unstructured":"Mokhtarian F, Shirazian D, Morgante L et al (1997) Influenza virus vaccination of patients with multiple sclerosis. Mult Scler 3:243\u2013247","journal-title":"Mult Scler"},{"key":"2865_CR47","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1016\/S0264-410X(99)00533-2","volume":"18","author":"Monteyne","year":"2000","unstructured":"Monteyne P, Andr\u00e9 FE (2000) Is there a causal link between hepatitis B vaccination and multiple sclerosis? Vaccine 18:1994\u20132001","journal-title":"Vaccine"},{"key":"2865_CR48","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1212\/WNL.56.7.938","volume":"56","author":"Moriabadi","year":"2001","unstructured":"Moriabadi NF, Niewiesk S, Kruse N et al (2001) Influenza vaccination in MS: absence of T-cell response against white matter proteins. Neurology 56:938\u2013943","journal-title":"Neurology"},{"key":"2865_CR49","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1007\/s00415-008-0061-1","volume":"255","author":"Multiple","year":"2008","unstructured":"Multiple Sclerosis Therapy Consensus Group (MSTCG), Wiendl H, Toyka KV et al (2008) Basic and escalating immunomodulatory treatments in multiple sclerosis: current therapeutic recommendations. J Neurol 255(10):1449\u20131463","journal-title":"J Neurol"},{"key":"2865_CR50","doi-asserted-by":"crossref","first-page":"S546","DOI":"10.1093\/infdis\/136.Supplement_3.S546","volume":"136","author":"Myers","year":"1977","unstructured":"Myers LW, Ellison GW, Lucia M et al (1977) Swine influenza virus vaccination in patients with multiple sclerosis. J Infect Dis 136:S546\u2013S554","journal-title":"J Infect Dis"},{"key":"2865_CR51","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/00019052-200206000-00018","volume":"15","author":"Piyasirisilp","year":"2002","unstructured":"Piyasirisilp S, Hemachudha T (2002) Neurological adverse events associated with vaccination. Curr Opin Neurol 15:333\u2013338","journal-title":"Curr Opin Neurol"},{"key":"2865_CR52","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1146\/annurev.me.29.020178.003055","volume":"29","author":"Plotkin","year":"1978","unstructured":"Plotkin SA, Wiktor T (1978) Rabies vaccination. Annu Rev Med 29:583\u2013591","journal-title":"Annu Rev Med"},{"key":"2865_CR53","unstructured":"Oren S, Mendelboim M, Brawn Y et al (2007) Vaccination against influenza in rheumatoid arthritis patients: the effect of rituximab on the humoral response. Ann Rheum Dis 66 [Suppl II]:363 (Abstr FRI0275)"},{"key":"2865_CR54","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/0264-410X(91)90104-E","volume":"9","author":"Quast","year":"1991","unstructured":"Quast U, Herder C, Zwisler O (1991) Vaccination of patients with encephalomyelitis disseminata. Vaccine 9:228\u2013230","journal-title":"Vaccine"},{"key":"2865_CR55","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1007\/s001150170014","volume":"72","author":"Rieckmann","year":"2001","unstructured":"Rieckmann P, Moriabadi N, Flachenecker P, Toyka K (2001) Anmerkung zum Beitrag von In: Zipp F, Wandinger KP (Hrsg) Aktuelle Empfehlungen zu Impfungen bei Multipler Sklerose. Nervenarzt 72(12):972","journal-title":"Nervenarzt"},{"key":"2865_CR56","unstructured":"Rieckmann P, Toyka KV, Multiple Sclerosis Therapy Consensus Group (2002) Immunomodulatory staged therapy of multiple sclerosis. New aspects and practical applications, Nervenarzt 73(6):556\u2013563"},{"key":"2865_CR57","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1212\/WNL.53.7.1588","volume":"53","author":"Ristori","year":"1999","unstructured":"Ristori G, Buzzi MG, Sabatini U et al (1999) Use of Bacille Calmette-Gu\u00e8rin (BCG) in multiple sclerosis. Neurology 53:1588\u20131589","journal-title":"Neurology"},{"key":"2865_CR58","first-page":"49","volume":"7","author":"RKI","year":"2002","unstructured":"RKI (2002) Zur Situation bei wichtigen Infektionskrankheiten Impfpr\u00e4ventable Krankheiten in Deutschland bis zum Jahr 2000. Epidemiol Bull 7:49\u201357","journal-title":"Epidemiol Bull"},{"key":"2865_CR59","unstructured":"RKI (2007) F\u00fcnfjahresinzidenz der Fr\u00fchsommer-Meningoenzephalitis in Kreisen und Kreisregionen, Deutschland, 2002 bis 2006. Epidemiol Bull 15"},{"key":"2865_CR60","first-page":"193","volume":"24","author":"RKI","year":"2008","unstructured":"RKI (2008) Tetanus: Zwei Fallberichte zu Erkrankungen. Epidemiol Bull 24:193\u2013196","journal-title":"Epidemiol Bull"},{"key":"2865_CR61","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0895-4356(96)00374-5","volume":"50","author":"Ross","year":"1997","unstructured":"Ross RT, Cheang M (1997) Common infectious diseases in a population with low multiple sclerosis and varicella occurrence. J Clin Epidemiol 50:337\u2013339","journal-title":"J Clin Epidemiol"},{"key":"2865_CR62","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0895-4356(96)00300-9","volume":"50","author":"Ross","year":"1997","unstructured":"Ross RT, Nicolle LE, Cheang M (1997) The varicella zoster virus: a pilot trial of a potential therapeutic agent in multiple sclerosis. J Clin Epidemiol 50(1):63\u201368","journal-title":"J Clin Epidemiol"},{"key":"2865_CR63","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1212\/WNL.59.12.1837","volume":"59","author":"Rutschmann","year":"2002","unstructured":"Rutschmann OT, McCrory DC, Matchar DB (2002) Immunization Panel of Multiple sclerosis Council for Clinical Practice Guidelines. Immunization and MS: a summary of published evidence and recommendations. Neurology 59:1837\u20131843","journal-title":"Neurology"},{"key":"2865_CR64","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0140-6736(99)02991-8","volume":"355","author":"Sadovnick","year":"2000","unstructured":"Sadovnick AD, Scheifele DW (2000) School-based hepatitis B vaccination programme and adolescent multiple sclerosis. Lancet 355:549\u2013550","journal-title":"Lancet"},{"key":"2865_CR65","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/BF00936886","volume":"242","author":"Salvetti","year":"1995","unstructured":"Salvetti M, Pisani A, Bastianello S et al (1995) Clinical and MRI assessment of disease activity in patients with multiple sclerosis after influenza vaccination. J Neurol 242:143\u2013146","journal-title":"J Neurol"},{"key":"2865_CR66","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/00007890-200002150-00023","volume":"69","author":"Sanchez-Fructuoso","year":"2000","unstructured":"Sanchez-Fructuoso AI, Prats D, Naranjo P et al (2000) Influenza virus immunization effectivity in kidney transplant patients subjected to two different triple-drug therapy immunosuppression protocols. Transplantation 69(3):436\u2013439","journal-title":"Transplantation"},{"key":"2865_CR67","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1007\/s00115-003-1677-0","volume":"75","author":"Schattenfroh","year":"2004","unstructured":"Schattenfroh C (2004) Akute demyelinisierende Enzephalomyelitis nach aktiver Immunisierung gegen Fr\u00fchsommer-Meningoencephalitits. Nervenarzt 75:776\u2013779","journal-title":"Nervenarzt"},{"key":"2865_CR68","doi-asserted-by":"crossref","first-page":"3876","DOI":"10.1016\/j.vaccine.2005.03.005","volume":"23","author":"Schattner","year":"2005","unstructured":"Schattner A (2005) Consequence or coincidence? The occurrence, pathogenesis and significance of autoimmune manifestations after viral vaccines. Vaccine 23:3876\u20133886","journal-title":"Vaccine"},{"key":"2865_CR69","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1212\/01.wnl.0000188901.12700.e0","volume":"65","author":"Schwid","year":"2005","unstructured":"Schwid SR, Decker MD, Lopez-Bresnahan M for the Rebif Influenza Vaccine Study Investigators (2005) Immune response to influenza vaccine is maintained in patients with MS receiving interferon-beta 1a. Neurology 65(12):1964\u20131466","journal-title":"Neurology"},{"key":"2865_CR70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/jaut.1999.0346","volume":"14","author":"Shoenfeld","year":"2000","unstructured":"Shoenfeld Y, Aron-Maor A (2000) Vaccination and autoimmunity-\u2019vaccinosis\u2019: a dangerous liaison? J Autoimmun 14:1\u201310","journal-title":"J Autoimmun"},{"key":"2865_CR71","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1001\/jama.1976.03270180041018","volume":"236","author":"Sibley","year":"1976","unstructured":"Sibley WA, Bamford CR, Laguna JF (1976) Influenza vaccination in patients with multiple sclerosis. JAMA 236:1965\u20131966","journal-title":"JAMA"},{"key":"2865_CR72","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1749-6632.1965.tb20229.x","volume":"122","author":"Sibley","year":"1965","unstructured":"Sibley WA, Foley JM (1965) Infection and immunization in multiple sclerosis. Ann N Y Acad Sci 122:457\u2013466","journal-title":"Ann N Y Acad Sci"},{"key":"2865_CR73","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1708-8305.2007.00168.x","volume":"15","author":"Shah","year":"2008","unstructured":"Shah I (2008) Acute demyelinating encephalomyelitis due to neural antirabies vaccine. J Travel Med 15:58\u201359","journal-title":"J Travel Med"},{"key":"2865_CR74","first-page":"268","volume":"30","author":"STIKO","year":"2007","unstructured":"STIKO (2007) Empfehlungen der St\u00e4ndigen Impfkommission (STIKO) am Robert Koch-Institut\/Stand: Juli 2007. Epidemiol Bull 30:268\u2013286","journal-title":"Epidemiol Bull"},{"key":"2865_CR75","doi-asserted-by":"crossref","unstructured":"S\u00fcss J, Schrader C, Falk U, Wohanka N (2004) Tick-borne encephalitis (TBE) in Germany \u2013 epidemiological data, development of risk areas and virus prevalence in field-collected ticks and in ticks removed from humans. Int J Med Microbiol 293 [Suppl 37]:69\u201379","DOI":"10.1016\/S1433-1128(04)80011-1"},{"key":"2865_CR76","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1177\/1352458508096868","volume":"15","author":"Sutton","year":"2009","unstructured":"Sutton I, Lahoria R, Tan I et al (2009) CNS demyelination and quadrivalent HPV vaccination. Mult Scler 15:116\u2013119","journal-title":"Mult Scler"},{"key":"2865_CR77","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1086\/590116","volume":"198","author":"Tauber","year":"2008","unstructured":"Tauber E, Kollaritsch H, von Sonnenburg F et al (2008) Randomized, double-blind, placebo-controlled phase 3 trial of the safety and tolerability of IC51, an inactivated Japanese encephalitis vaccine. J Infect Dis 198(4):493\u2013499","journal-title":"J Infect Dis"},{"key":"2865_CR78","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1159\/000059520","volume":"21","author":"Touz\u00e9","year":"2002","unstructured":"Touz\u00e9 E, Fourrier A, Rue-Fenouche C et al (2002) Hepatitis B vaccination and first central nervous system demyelinating event: a case-control study. Neuroepidemiology 21:180\u2013186","journal-title":"Neuroepidemiology"},{"key":"2865_CR79","doi-asserted-by":"crossref","first-page":"92","DOI":"10.4161\/hv.5.2.6587","volume":"5","author":"Van","year":"2009","unstructured":"Van Damme P, Minervini G, Liss CL et al (2009) Safety, tolerability and immunogenicity of a recombinant hepatitis B vaccine manufactured by a modified process in healthy young adults. Hum Vaccin 5(2):92\u201397","journal-title":"Hum Vaccin"},{"key":"2865_CR80","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1182\/blood.V100.6.2257","volume":"100","author":"Van","year":"2002","unstructured":"Van der Kolk LE, Baars JW, Prins MH et al (2002) Rituximab treatment results in impaired secondary humoral immune responsiveness. Blood 100(6):2257\u20132259","journal-title":"Blood"},{"key":"2865_CR81","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1086\/597006","volume":"48","author":"Veit","year":"2009","unstructured":"Veit O, Niedrig M, Chapuis-Taillard C et al (2009) Immunogenicity and safety of yellow fever vaccination for 102 HIV-infected patients. Clin Infect Dis 48(5):659\u2013666","journal-title":"Clin Infect Dis"},{"key":"2865_CR82","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/00007890-198610000-00009","volume":"42","author":"Versluis","year":"1986","unstructured":"Versluis DJ, Beyer WE, Masurel N et al (1986) Impairment of the immune response to influenza vaccination in renal transplant recipients by cyclosporine, but not azathioprine. Transplantation 42(4):376\u2013379","journal-title":"Transplantation"},{"key":"2865_CR83","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.mehy.2005.05.009","volume":"65","author":"Verstraeten","year":"2005","unstructured":"Verstraeten T, Davis R, DeStefano F (2005) Immunity to tetanus is protective against the development of multiple sclerosis. Med Hypotheses 65:966\u2013969","journal-title":"Med Hypotheses"},{"key":"2865_CR84","first-page":"350","volume":"72","author":"Wagner","year":"1994","unstructured":"Wagner D, Wagenbreth I, Stachan-Kunstyr R et al (1994) Hepatitis B vaccination of immunosuppressed heart transplant recipients with the vaccine Hepa Gene 3 containing pre-S1, pre-S2 and S gene products. Clin Invest 72:350\u2013352","journal-title":"Clin Invest"},{"key":"2865_CR85","doi-asserted-by":"crossref","unstructured":"Wenzel HH, Jahnel J, Hoegenauer C et al (2003) Inadequately low antibodies against the tick-borne encephalitis virus in immunized patients with inflammatory bowel disease and azathioprine treatment. Dig Dis Week Abstr S 1375","DOI":"10.1016\/S0016-5085(03)81029-6"},{"key":"2865_CR86","unstructured":"WHO (2008) Cumulative number of confirmed human cases of avian influenza A\/(H5N1) Reported to WHO, 19 June 2008. Online: http:\/\/www.who.int\/csr\/disease\/avian_influenza\/country\/cases_table_2008_06_19\/en\/index.html [01.09.2008]"},{"key":"2865_CR87","unstructured":"WHO (2009) Vaccines for the new influenza A (H1N1). Online: http:\/\/www.who.int\/csr\/disease\/swineflu\/frequently_asked_questions\/vaccine_preparedness\/en\/index.html [20.06.2009]"},{"key":"2865_CR88","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00508-005-0362-7","volume":"117","author":"Wormser","year":"2005","unstructured":"Wormser GP (2005) Prevention of Lyme borreliosis. Wien Klin Wochenschr 117:385\u2013391","journal-title":"Wien Klin Wochenschr"},{"key":"2865_CR89","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1086\/597401","volume":"48","author":"Wu","year":"2009","unstructured":"Wu J, Fang HH, Chen JT et al (2009) Immunogenicity, safety, and cross-reactivity of an inactivated, adjuvanted, prototype pandemic influenza (H5N1) vaccine: a phase II, double-blind, randomized trial. Clin Infect Dis 48:1087\u20131095","journal-title":"Clin Infect Dis"},{"key":"2865_CR90","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1172\/JCI200114235","volume":"108","author":"Wucherpfennig","year":"2001","unstructured":"Wucherpfennig KW (2001) Mechanisms for the induction of autoimmunity by infectious agents. J Clin Invest 108:1097\u20131104","journal-title":"J Clin Invest"},{"key":"2865_CR91","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1007\/s001150170039","volume":"72","author":"Zipp","year":"2001","unstructured":"Zipp F, Wandinger KP (2001) Aktuelle Empfehlungen zu Impfungen bei Multipler Sklerose. Nervenarzt 72(10):802\u2013806","journal-title":"Nervenarzt"},{"key":"2865_CR92","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1038\/12376","volume":"5","author":"Zipp","year":"1999","unstructured":"Zipp F, Weil JG, Einh\u00e4upl KM (1999) No increase in demyelinating diseases after hepatitis B vaccination. Nat Med 5:964\u2013965","journal-title":"Nat Med"},{"key":"2865_CR93","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/jmv.20524","volume":"78","author":"Zuckerman","year":"2006","unstructured":"Zuckerman JN (2006) Protective efficacy, immunotherapeutic potential, and safety of hepatitis B vaccines. J Med Virol 78:169\u2013177","journal-title":"J Med Virol"}],"container-title":["Der Nervenarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-009-2865-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00115-009-2865-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-009-2865-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,23]],"date-time":"2020-05-23T03:03:09Z","timestamp":1590202989000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00115-009-2865-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10,17]]},"references-count":93,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["2865"],"URL":"https:\/\/doi.org\/10.1007\/s00115-009-2865-3","relation":{},"ISSN":["0028-2804","1433-0407"],"issn-type":[{"value":"0028-2804","type":"print"},{"value":"1433-0407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,10,17]]}}}